Fennec Pharmaceuticals (FENC) Revenue (2020 - 2026)
Fennec Pharmaceuticals' (FENC) quarterly Revenue came in at $13.8 million in Q4 2025, up 73.84% YoY from $7.9 million in Q4 2024, and up 10.55% on a QoQ basis from $12.5 million in Q3 2025.
Fennec Pharmaceuticals (FENC) Revenue (2020 - 2026) Analysis & Trends
Fennec Pharmaceuticals (FENC) has 4 years of Revenue data on file, last reported at $13.8 million in Q4 2025.
- Quarterly Revenue rose 73.84% year-over-year to $13.8 million in Q4 2025, while the trailing twelve-month figure through Dec 2025 was $44.6 million (down 6.09% YoY) and the FY2025 annual result came in at $44.6 million, down 6.09% from the prior year.
- Revenue improved to $13.8 million in Q4 2025, from $12.5 million in the prior quarter.
- In the past five years, Revenue ranged from a high of $25.4 million in Q1 2024 to a low of $1.7 million in Q1 2023.
- A 3-year average of $9.5 million and a median of $8.3 million in 2024 frame the typical range for Revenue.
- Annual changes were most pronounced in 2024 — Revenue jumped 1413.24% — and 2025, when it plunged 65.52%.
- Tracing FENC's Revenue over 3 years: stood at $9.7 million in 2023, then decreased by 18.59% to $7.9 million in 2024, then jumped by 73.84% to $13.8 million in 2025.
- The last three Revenue figures came in at $13.8 million (Q4 2025), $12.5 million (Q3 2025), and $9.7 million (Q2 2025), per Business Quant data.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Revenue (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 128.13 Bn | 120.28 Bn | 2.84 Bn | 3.33 Bn |
| 2 | Regeneron Pharmaceuticals | 112.33 Bn | 104.33 Bn | 3.93 Bn | 4.29 Bn |
| 3 | Argenx Se | 53.24 Bn | 48.05 Bn | 1.41 Bn | 1.56 Bn |
| 4 | Revolution Medicines | 43.64 Bn | 43.64 Bn | - | - |
| 5 | BeOne Medicines | 39.27 Bn | 34.17 Bn | 1.53 Bn | 1.71 Bn |
| 6 | MindWalk Holdings | 35.32 Bn | 35.31 Bn | 1.82 Bn | 3,001.92 |
| 7 | Royalty Pharma | 33.72 Bn | 35.84 Bn | - | 674.14 Mn |
| 8 | Alnylam Pharmaceuticals | 30.58 Bn | 27.27 Bn | 992.69 Mn | 1.29 Bn |
| 9 | Insmed | 27.01 Bn | 25.85 Bn | 358.27 Mn | 425.49 Mn |
| 10 | Fennec Pharmaceuticals | 410.60 Mn | 369.35 Mn | 17.15 Mn | 17.87 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 17.87 Mn |
| Dec 31, 2025 | 13.78 Mn |
| Sep 30, 2025 | 12.46 Mn |
| Jun 30, 2025 | 9.65 Mn |
| Mar 31, 2025 | 8.75 Mn |
| Dec 31, 2024 | 7.93 Mn |
| Sep 30, 2024 | 6.97 Mn |
| Jun 30, 2024 | 7.26 Mn |
| Mar 31, 2024 | 25.38 Mn |
| Dec 31, 2023 | 9.74 Mn |
| Sep 30, 2023 | 6.52 Mn |
| Jun 30, 2023 | 3.33 Mn |
| Mar 31, 2023 | 1.68 Mn |
| Dec 31, 2020 | 200,000.00 |